Dultz G - Search Results

1

Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years.

Graf C, Fuhrmann L, Lutz T, Stephan C, Knecht G, Gute P, Bickel M, Peiffer KH, Finkelmeier F, Dultz G, Mondorf A, Wetzstein N, Filmann N, Herrmann E, Zeuzem S, Beerenwinkel N, Dietz J, Sarrazin C. Graf C, et al. Among authors: dultz g. JHEP Rep. 2023 Feb 19;5(7):100701. doi: 10.1016/j.jhepr.2023.100701. eCollection 2023 Jul. JHEP Rep. 2023. PMID: 37305441 Free PMC article.

2

Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.

Dultz G, Kronenberger B, Azizi A, Mihm U, Vogl TJ, Sarrazin U, Sarrazin C, Zeuzem S, Hofmann WP. Dultz G, et al. J Hepatol. 2011 Jul;55(1):229-32. doi: 10.1016/j.jhep.2011.01.020. Epub 2011 Mar 23. J Hepatol. 2011. PMID: 21310200 Free article.

3

Acoustic radiation force impulse imaging for evaluation of antiviral treatment response in chronic hepatitis C.

Forestier N, Gaus A, Herrmann E, Sarrazin C, Bojunga J, Poynard T, Albert J, Gerber L, Schneider MD, Dultz G, Zeuzem S, Friedrich-Rust M. Forestier N, et al. Among authors: dultz g. J Gastrointestin Liver Dis. 2012 Dec;21(4):367-73. J Gastrointestin Liver Dis. 2012. PMID: 23256119 Free article.

4

Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis.

Dultz G, Seelhof M, Herrmann E, Welker MW, Friedrich-Rust M, Teuber G, Kronenberger B, von Wagner M, Vermehren J, Sarrazin C, Zeuzem S, Hofmann WP. Dultz G, et al. PLoS One. 2013 Aug 1;8(8):e71262. doi: 10.1371/journal.pone.0071262. Print 2013. PLoS One. 2013. PMID: 23936497 Free PMC article.

5

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors.

Welzel TM, Dultz G, Zeuzem S. Welzel TM, et al. Among authors: dultz g. J Hepatol. 2014 Nov;61(1 Suppl):S98-S107. doi: 10.1016/j.jhep.2014.08.014. Epub 2014 Nov 3. J Hepatol. 2014. PMID: 25443350 Free article. Review.

6

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis.

Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O. Dultz G, et al. Aliment Pharmacol Ther. 2015 Mar;41(5):459-66. doi: 10.1111/apt.13061. Epub 2014 Dec 19. Aliment Pharmacol Ther. 2015. PMID: 25523381 Free article. Clinical Trial.

7

Letter: proton pump inhibitors - severity of liver disease and mortality in patients with cirrhosis - authors' reply.

Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O. Dultz G, et al. Aliment Pharmacol Ther. 2015 Apr;41(7):706. doi: 10.1111/apt.13110. Aliment Pharmacol Ther. 2015. PMID: 25736154 Free article. No abstract available.

8

Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients--authors' reply.

Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O. Dultz G, et al. Aliment Pharmacol Ther. 2015 Jun;41(11):1225. doi: 10.1111/apt.13207. Aliment Pharmacol Ther. 2015. PMID: 25939474 Free article. No abstract available.

9

The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.

Dultz G, Gerber L, Zeuzem S, Sarrazin C, Waidmann O. Dultz G, et al. J Viral Hepat. 2016 Apr;23(4):267-73. doi: 10.1111/jvh.12488. Epub 2015 Nov 10. J Viral Hepat. 2016. PMID: 26554542

10

Hepatitis C Virus: A European Perspective.

Dultz G, Zeuzem S. Dultz G, et al. Gastroenterol Clin North Am. 2015 Dec;44(4):807-24. doi: 10.1016/j.gtc.2015.07.008. Epub 2015 Oct 1. Gastroenterol Clin North Am. 2015. PMID: 26600221 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page